Overview

A class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) and certain of the Company’s current and former senior executive officers (collectively, “Defendants”) alleging violations of the federal securities laws. The Company’s shares are listed on the New York Stock Exchange under the ticker symbol “UNH.”

The UnitedHealth class action lawsuit was brought on behalf of all persons or entities who purchased publicly traded UnitedHealth securities between December 3, 2024, and April 16, 2025, both dates inclusive (the “Class Period”).

UnitedHealth specializes in health insurance and health care services. The Company operates under two distinct, yet complementary brands: (1) UnitedHealthcare, under which the Company sells insurance products, and (2) Optum, under which the Company sells health care services.

The UnitedHealth class action lawsuit alleges that Defendants misrepresented and failed to disclose adverse facts pertaining to the Company’s business, operational and financial results, throughout the Class Period. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) UnitedHealth had engaged in a corporate strategy of denying health coverage in order to boost its profits and share price; (2) this anti-consumer strategy resulted in regulatory scrutiny against UnitedHealth that ultimately resulted in the murder of Brian Thompson; (3) animus towards UnitedHealth was such that, subsequent to the murder of Mr. Thompson, many Americans openly celebrated his demise, expressed admiration for his accused killer, and/or otherwise demanded that UnitedHealth change its strategy; (4) the foregoing regulatory and public outrage caused UnitedHealth to change its corporate practices; (5) notwithstanding the foregoing, UnitedHealth recklessly maintained the guidance it issued the day before Mr. Thompson’s murder, which was unrealistic considering the Company’s changing corporate strategies; and (6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

*          *          *

If you purchased or otherwise acquired UnitedHealth securities between December 3, 2024, and April 16, 2025, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at investors@dicellolevitt.com. 

The deadline to apply to the Court to serve as lead plaintiff in the UnitedHealth class action lawsuit is July 7, 2025.